📄 论文动态
These 15 papers illustrate the expanding role of AI in healthcare, from clinical decision support and autonomous systems to large language models for patient education, communication, and research support. Key themes include the feasibility of AI in resource-limited settings (e.g., prehospital trauma triage), the rise of LLMs in patient-facing and team-based applications, explainability and privacy concerns, and the growing importance of AI in drug discovery and health workforce training. High-impact studies, such as the SAVE-O2 RCT and autonomous ophthalmic diagnosis, provide early clinical evidence, while foundational reviews in Lancet and Nature Reviews Drug Discovery highlight systemic challenges and future pathways. Non-AI cancer research papers complement the translational landscape.
### 🏭 行业动态
The industry news centers on regulatory evolution and market growth for AI in healthcare. The FDA is simplifying approval pathways for AI-enabled medical devices, issuing guidance for SaMD, and responding to stakeholder feedback (e.g., AHA letters). Market reports project substantial growth in AI healthcare solutions. Major tech players like Google DeepMind are advancing the concept of an 'AI co-clinician', signaling a shift toward AI-augmented care. These developments suggest a maturing ecosystem with clearer regulatory frameworks and increasing commercial investment.
### 📊 高频期刊 TOP10
| 期刊 | IF | 篇数 |
|:---|---:|---:|
| Int J Med Inform | 5.5 | 3 |
| Digit Health | 23.8 | 2 |
| Lancet | 98.4 | 1 |
| Artif Intell Med | 5.1 | 1 |
| Nat Rev Drug Discov | 120.1 | 1 |
| J Am Med Inform Assoc | 6.4 | 1 |
| Cell Rep Med | 45.5 | 1 |
| J Nucl Med Technol | 7.4 | 1 |
| JMIR AI | 5.8 | 1 |
| Cancer Res | 10.0 | 1 |
## 二、研究主题聚类
### Large Language Models in Healthcare
7 篇
LLMs are expanding from simple patient education to teamwork, communication, multi-agent frameworks, and research support. Emphasis is on privacy, explainability, and linguistic/cultural adaptation, with a trend toward hybrid human-AI workflows.
Clinical AI Systems for Diagnosis and Treatment
3 篇
AI is moving from assistive tools to autonomous agents (e.g., oxygen titration, multimodal diagnosis). Randomized trials and real-world validation are becoming critical, with applications spanning prehospital to hospital settings.
AI in Drug Discovery and Basic Cancer Research
3 篇
AI is accelerating drug target identification and development, while basic cancer research (e.g., glucocorticoid receptor, anti-CTLA-4 antibodies) continues to provide novel therapeutic insights. The integration of AI with foundational biology is expected to enhance precision medicine.
Medical Education and Health Workforce
2 篇
AI is reshaping medical education and workforce requirements, necessitating new curricula and skills. Global initiatives emphasize the imperative to prepare healthcare professionals for AI-augmented practice.